BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seo J, Hur K, Ko Y, Kim K, Lee B, Kim Y, Kim S, Kim S, Lee Y, Kim H, Lee S, Jang C. A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents. Brain Research Bulletin 2019;152:19-26. [DOI: 10.1016/j.brainresbull.2019.07.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Hur K, Lee Y, Donio AL, Lee J, Lee B, Kim S, Yoon S, Lee Y, Kim H, Lee S, Jang C. Mepirapim, a novel synthetic cannabinoid, induces Parkinson’s disease-related behaviors by causing maladaptation of the dopamine system in the brain. Arch Toxicol 2022. [DOI: 10.1007/s00204-022-03414-y] [Reference Citation Analysis]
2 Demin KA, Kupriyanova OV, Shevyrin VA, Derzhavina KA, Krotova NA, Ilyin NP, Kolesnikova TO, Galstyan DS, Kositsyn YM, Khaybaev AS, Seredinskaya MV, Dubrovskii Y, Sadykova RG, Nerush MO, Mor MS, Petersen EV, Strekalova T, Efimova EV, Kuvarzin SR, Yenkoyan KB, Bozhko DV, Myrov VO, Kolchanova SM, Polovian AI, Galumov GK, Kalueff AV. Acute behavioral and Neurochemical Effects of Novel N-Benzyl-2-Phenylethylamine Derivatives in Adult Zebrafish. ACS Chem Neurosci 2022. [PMID: 35671176 DOI: 10.1021/acschemneuro.2c00123] [Reference Citation Analysis]
3 Potts AJ, Thomas SH, Hill SL. Pharmacology and toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) hallucinogens. Novel Psychoactive Substances 2022. [DOI: 10.1016/b978-0-12-818788-3.00008-5] [Reference Citation Analysis]
4 Lee B, Sung S, Hur K, Kim S, Ma S, Kim S, Ko Y, Kim Y, Lee Y, Lee S, Jang C. Korean Red Ginseng inhibits methamphetamine addictive behaviors by regulating dopaminergic and NMDAergic system in rodents. Journal of Ginseng Research 2022;46:147-55. [DOI: 10.1016/j.jgr.2021.05.007] [Reference Citation Analysis]
5 Ryu IS, Kim OH, Kim JS, Sohn S, Choe ES, Lim RN, Kim TW, Seo JW, Jang EY. Effects of β-Phenylethylamine on Psychomotor, Rewarding, and Reinforcing Behaviors and Affective State: The Role of Dopamine D1 Receptors. Int J Mol Sci 2021;22:9485. [PMID: 34502393 DOI: 10.3390/ijms22179485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hur KH, Kim SE, Ma SX, Lee BR, Ko YH, Seo JY, Kim SK, Kim YJ, Sung SJ, Lee Y, Jung YH, Lee YS, Lee SY, Jang CG. Methoxphenidine (MXP) induced abnormalities: Addictive and schizophrenia-related behaviours based on an imbalance of neurochemicals in the brain. Br J Pharmacol 2021;178:3869-87. [PMID: 33987827 DOI: 10.1111/bph.15528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Rudin D, Liechti ME, Luethi D. Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Exp Neurol 2021;343:113778. [PMID: 34090893 DOI: 10.1016/j.expneurol.2021.113778] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
8 Herian M, Skawski M, Wojtas A, Sobocińska MK, Noworyta K, Gołembiowska K. Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe. Psychopharmacology (Berl) 2021;238:2349-64. [PMID: 34032876 DOI: 10.1007/s00213-021-05860-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
9 Giorgetti A, Pascali JP, Fais P, Pelletti G, Gabbin A, Franchetti G, Cecchetto G, Viel G. Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications. Life (Basel) 2021;11:440. [PMID: 34068903 DOI: 10.3390/life11050440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Kim YJ, Ma SX, Hur KH, Lee Y, Ko YH, Lee BR, Kim SK, Sung SJ, Kim KM, Kim HC, Lee SY, Jang CG. New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents. Arch Toxicol 2021;95:1413-29. [PMID: 33515270 DOI: 10.1007/s00204-021-02980-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Custodio RJP, Sayson LV, Botanas CJ, Abiero A, You KY, Kim M, Lee HJ, Yoo SY, Lee KW, Lee YS, Seo JW, Ryu IS, Kim HJ, Cheong JH. 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential. Addict Biol 2020;25:e12850. [PMID: 31749223 DOI: 10.1111/adb.12850] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
12 Hur K, Kim S, Lee B, Ko Y, Seo J, Kim S, Ma S, Kim Y, Jeong Y, Pham DT, Trinh QD, Shin E, Kim H, Lee Y, Lee S, Jang C. 25C-NBF, a new psychoactive substance, has addictive and neurotoxic potential in rodents. Arch Toxicol 2020;94:2505-16. [DOI: 10.1007/s00204-020-02740-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Luethi D, Liechti ME. Designer drugs: mechanism of action and adverse effects. Arch Toxicol 2020;94:1085-133. [PMID: 32249347 DOI: 10.1007/s00204-020-02693-7] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 38.0] [Reference Citation Analysis]
14 Zawilska JB, Kacela M, Adamowicz P. NBOMes-Highly Potent and Toxic Alternatives of LSD. Front Neurosci 2020;14:78. [PMID: 32174803 DOI: 10.3389/fnins.2020.00078] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]